Boston Scientific Corporation (0HOY.L)
USD 93.57
(1.68%)
USD 93.57
(1.68%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 8.56 Billion USD | -3.86% |
| 2022 | 8.91 Billion USD | 1.27% |
| 2021 | 8.79 Billion USD | -3.56% |
| 2020 | 9.12 Billion USD | 6.25% |
| 2019 | 8.58 Billion USD | 78.76% |
| 2018 | 4.8 Billion USD | 25.9% |
| 2017 | 3.81 Billion USD | -29.61% |
| 2016 | 5.42 Billion USD | -4.48% |
| 2015 | 5.67 Billion USD | 47.72% |
| 2014 | 3.84 Billion USD | -9.52% |
| 2013 | 4.24 Billion USD | -0.16% |
| 2012 | 4.25 Billion USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 9.53 Billion USD | 11.25% |
| 2024 Q2 | 8.98 Billion USD | -5.7% |
| 2024 Q3 | 9.22 Billion USD | 2.69% |
| 2023 FY | 8.56 Billion USD | -3.86% |
| 2023 Q4 | 8.56 Billion USD | 2.15% |
| 2023 Q2 | 8.49 Billion USD | -0.01% |
| 2023 Q3 | 8.38 Billion USD | -1.27% |
| 2023 Q1 | 8.49 Billion USD | -4.66% |
| 2022 Q4 | 8.91 Billion USD | 4.04% |
| 2022 Q2 | 8.8 Billion USD | -2.92% |
| 2022 Q1 | 9.06 Billion USD | 3.06% |
| 2022 FY | 8.91 Billion USD | 1.27% |
| 2022 Q3 | 8.56 Billion USD | -2.7% |
| 2021 Q2 | 8.84 Billion USD | -6.23% |
| 2021 Q4 | 8.79 Billion USD | -0.29% |
| 2021 FY | 8.79 Billion USD | -3.56% |
| 2021 Q3 | 8.82 Billion USD | -0.26% |
| 2021 Q1 | 9.43 Billion USD | -1.01% |
| 2020 FY | 9.12 Billion USD | 6.25% |
| 2020 Q1 | 9.6 Billion USD | 8.25% |
| 2020 Q2 | 9.54 Billion USD | -0.61% |
| 2020 Q4 | 9.53 Billion USD | -0.52% |
| 2020 Q3 | 9.58 Billion USD | 0.42% |
| 2019 Q3 | 9.84 Billion USD | 26.23% |
| 2019 Q2 | 7.79 Billion USD | -0.06% |
| 2019 FY | 8.58 Billion USD | 78.76% |
| 2019 Q1 | 7.8 Billion USD | 62.42% |
| 2019 Q4 | 8.86 Billion USD | -9.89% |
| 2018 Q2 | 4.8 Billion USD | 0.1% |
| 2018 Q1 | 4.8 Billion USD | 25.9% |
| 2018 FY | 4.8 Billion USD | 25.9% |
| 2018 Q4 | 4.8 Billion USD | -0.06% |
| 2018 Q3 | 4.8 Billion USD | -0.04% |
| 2017 Q4 | 3.81 Billion USD | -13.61% |
| 2017 FY | 3.81 Billion USD | -29.61% |
| 2017 Q2 | 4.81 Billion USD | -12.56% |
| 2017 Q1 | 5.5 Billion USD | 1.64% |
| 2017 Q3 | 4.41 Billion USD | -8.32% |
| 2016 Q1 | 5.42 Billion USD | -4.41% |
| 2016 Q4 | 5.42 Billion USD | 4.82% |
| 2016 Q3 | 5.17 Billion USD | -0.04% |
| 2016 Q2 | 5.17 Billion USD | -4.63% |
| 2016 FY | 5.42 Billion USD | -4.48% |
| 2015 Q2 | 5.06 Billion USD | 31.83% |
| 2015 FY | 5.67 Billion USD | 47.72% |
| 2015 Q4 | 5.67 Billion USD | -2.1% |
| 2015 Q3 | 5.79 Billion USD | 14.34% |
| 2015 Q1 | 3.84 Billion USD | 0.1% |
| 2014 Q2 | 4.25 Billion USD | 0.16% |
| 2014 Q3 | 4.24 Billion USD | -0.07% |
| 2014 Q4 | 3.84 Billion USD | -9.6% |
| 2014 FY | 3.84 Billion USD | -9.52% |
| 2014 Q1 | 4.24 Billion USD | 0.0% |
| 2013 Q2 | 3.64 Billion USD | -14.19% |
| 2013 Q1 | 4.25 Billion USD | -0.05% |
| 2013 FY | 4.24 Billion USD | -0.16% |
| 2013 Q3 | 4.24 Billion USD | 16.42% |
| 2013 Q4 | 4.24 Billion USD | -0.02% |
| 2012 Q4 | 4.25 Billion USD | 0.0% |
| 2012 FY | 4.25 Billion USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Phreesia, Inc. | 2.04 Million USD | -417957.589% |
| Accuray Incorporated | 164.4 Million USD | -5110.462% |
| Align Technology, Inc. | 96.96 Million USD | -8733.842% |
| Elevance Health Inc. | 23.24 Billion USD | 63.151% |
| AxoGen, Inc. | 46.6 Million USD | -18280.791% |
| CVS Health Corporation | 74.67 Billion USD | 88.528% |
| Cardinal Health, Inc. | 4.58 Billion USD | -86.908% |
| Centene Corporation | 17.69 Billion USD | 51.602% |
| DaVita Inc. | 8.05 Billion USD | -6.393% |
| HCA Healthcare, Inc. | 36.62 Billion USD | 76.614% |
| Hologic, Inc. | 2.49 Billion USD | -243.038% |
| Humana Inc. | 10.21 Billion USD | 16.127% |
| IDEXX Laboratories, Inc. | 622.88 Million USD | -1275.218% |
| Laboratory Corporation of America Holdings | 4.05 Billion USD | -111.261% |
| Masimo Corporation | 871.7 Million USD | -882.678% |
| McKesson Corporation | 5.45 Billion USD | -57.145% |
| Patterson Companies, Inc. | 328.91 Million USD | -2504.352% |
| Quest Diagnostics Incorporated | 4.41 Billion USD | -94.24% |
| ResMed Inc. | 697.31 Million USD | -1128.43% |
| Henry Schein, Inc. | 1.93 Billion USD | -343.145% |
| Teladoc Health, Inc. | 1.58 Billion USD | -441.629% |
| Universal Health Services, Inc. | 4.71 Billion USD | -81.632% |
| Veeva Systems Inc. | 46.44 Million USD | -18344.909% |
| Baxter International Inc. | 11.06 Billion USD | 22.578% |
| Becton, Dickinson and Company | 14.73 Billion USD | 41.878% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 10533.618% |
| Danaher Corporation | 17.66 Billion USD | 51.498% |
| Stryker Corporation | 10.9 Billion USD | 21.42% |
| Medtronic plc | 23.87 Billion USD | 64.124% |